Debut Plus

₹232.43

▼ -18.03 -7.20%

17 Jul 2026

NSE Listed · Pharmaceuticals

ASM 1

Sun Pharma Adv.Res.Co.Ltd (SPARC)

Volume: 6,00,557Avg Vol 1W: 3,29,095Avg Vol 1M: 18,52,75452W Range:₹108₹289
NSE BSE www.sparc.life
Key Ratios
Checked 2h ago
Market Cap₹7,807 Cr
Current Price₹232.43
Previous Close₹250.46
High / Low (52w)₹289 / ₹108
Volume6,00,557
Avg Vol (1W)3,29,095
Avg Vol (1M)18,52,754
Stock P/E4.99
Book Value₹41.26
Dividend Yield0%
ROE116.01%
ROA71.55%
Revenue (TTM)—
Revenue Growth-5%
Profit Margin3,967.31%
Total Debt₹100 Cr
Shares Outstanding32 Cr
Face Value₹1
EPS (TTM)₹48.24
P/B5.83
Debt / Equity0
50 DMA₹244.33
200 DMA₹175.24
Day change-7.20%
SurveillanceASM 1 (as of 2026-07-17)
Price Chart
₹232.43▲ 74.09% · 1Y
₹278₹10912.2Cr
2025-11-24
2026-07-17

20-day avg volume: 19.9L shares

Pros
  • Healthy return on equity of 116.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 30% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹17 Cr₹13 Cr₹15 Cr₹27 Cr₹10 Cr₹8 Cr₹8 Cr₹1,853 Cr
EBITDA₹-95 Cr₹-106 Cr₹-77 Cr₹-56 Cr₹-46 Cr₹-68 Cr₹-59 Cr₹1,773 Cr
Net Profit₹-96 Cr₹-107 Cr₹-80 Cr₹-60 Cr₹-52 Cr₹-76 Cr₹-80 Cr₹1,761 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹87 Cr₹258 Cr₹144 Cr₹250 Cr₹105 Cr₹74 Cr
EBITDA₹-310 Cr₹-140 Cr₹-190 Cr₹-215 Cr₹-385 Cr₹-334 Cr
Net Profit₹-312 Cr₹-151 Cr₹-203 Cr₹-223 Cr₹-387 Cr₹-343 Cr
EPS-11.92-5.77-7.73-7.82-11.93-10.55
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹273 Cr₹230 Cr₹280 Cr₹830 Cr₹515 Cr₹336 Cr
Total Liabilities₹291 Cr₹398 Cr₹249 Cr₹317 Cr₹389 Cr₹552 Cr
Equity₹-19 Cr₹-168 Cr₹31 Cr₹513 Cr₹126 Cr₹-217 Cr
Total Debt₹6 Cr₹113 Cr₹0 Cr———
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-150 Cr₹-213 Cr₹-74 Cr₹-425 Cr₹-369 Cr
Investing₹2 Cr₹-29 Cr₹-548 Cr₹392 Cr₹158 Cr
Financing₹159 Cr₹229 Cr₹617 Cr₹42 Cr₹199 Cr
Free Cash Flow₹-150 Cr₹-213 Cr₹-74 Cr₹-425 Cr₹-369 Cr
Shareholding
Promoter 65.67% Institutions 2.57% Public 31.76%
Efficiency & Working Capital
ROCE80.9%
Interest Coverage-36.9
Dividend Payout—
Debtor Days82 d
Inventory Days0 d
Payable Days579 d
Cash Conversion Cycle-498 d
Working Capital Days82 d
Shareholding Details

As of 2026-05-31

Promoter65.7%
FII2.5%
DII0.1%
Institutions2.6%
Public31.8%
Promoter Pledge0%
No. of Shareholders1,37,538
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026May 2026May 2026
Promoters65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%
FIIs3.3%3.2%2.6%2.1%2.2%1.4%1.5%1.8%2%2%2.5%2.5%
DIIs0.8%0.8%0.2%0.2%0.6%1.1%1%1%0.8%0.9%0.1%0.1%
Public30.2%30.3%31.5%32%31.5%31.8%31.9%31.5%31.5%31.4%31.8%31.8%
Promoter Pledge2.8%2.8%2.8%2.8%0%0%0%0%0%0%0%0%
No. of Shareholders1,03,9901,02,7431,25,1841,28,2051,31,0341,42,8641,40,7241,36,9971,44,8101,40,6251,37,5381,37,538
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Shanghvi Finance Private LimitedShareholding of Promoter and Promoter Group42.3%13.72 Cr
Dilip.s.shanghviShareholding of Promoter and Promoter Group19.1%6.18 Cr
Sun Pharmaceutical Industries Key Employees Benefit TrustPublic Shareholding3.2%1.03 Cr
Lakshdeep Investments & Finance (p) Ltd.Public Shareholding1.9%60,33,835
Aditya Medisales LimitedShareholding of Promoter and Promoter Group1.5%48,88,126
Raksha Sudhir ValiaShareholding of Promoter and Promoter Group1.3%41,45,231
Paresh Mohanlal ParekhPublic Shareholding1.1%36,51,837
Vijay Mohanlal ParekhPublic Shareholding1.1%36,65,304
Enam Securities Private LimitedPublic Shareholding1%33,70,786
Sudhir Vrundavandas ValiaShareholding of Promoter and Promoter Group0.6%18,33,951
Unimed Investments LimitedShareholding of Promoter and Promoter Group0.4%12,67,963
Vibha Dilip ShanghviShareholding of Promoter and Promoter Group0.3%10,63,236
Aalok Dilip ShanghviShareholding of Promoter and Promoter Group0.1%3,50,162
Vidhi Dilip ShanghviShareholding of Promoter and Promoter Group0.1%3,44,081
Shanghvi Family & Friends Benefit TrustShareholding of Promoter and Promoter Group0.1%1,54,922
Kumud Shantilal ShanghviShareholding of Promoter and Promoter Group0%38,795
Flamboyawer Finance Private LimitedShareholding of Promoter and Promoter Group0%2,543
Sanghvi Properties Private LimitedShareholding of Promoter and Promoter Group0%1,887
Gujarat Sun Pharmaceutical Industries Pvt LtdShareholding of Promoter and Promoter Group0%1,751
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Dilip.s.shanghvi00%2026-05-22
Sudhir Vrundavandas Valia00%2026-05-22
Vibha Dilip Shanghvi00%2026-05-22
Aalok Dilip Shanghvi00%2026-05-22
Vidhi Dilip Shanghvi00%2026-05-22
Kumud Shantilal Shanghvi00%2026-05-22
Aditya Medisales Limited00%2026-05-22
Raksha Sudhir Valia00%2026-05-22
Unimed Investments Limited00%2026-05-22
Shanghvi Family & Friends Benefit Trust00%2026-05-22
Shanghvi Finance Private Limited00%2026-05-22
Flamboyawer Finance Private Limited00%2026-05-22
Board of Directors
NameDesignationYear
T RajamannarNon Executive Director2025
Bhavna DoshiIndependent Director2025
Ferzaan EngineerIndependent Director2025
Robert SpiegelIndependent Director2025
Dilip S ShanghviChairman (Non-Executive)2025
Kajal Damania.Company Sec. & Compli. Officer2025
Vidhi ShanghviNon Executive Director2025
Rekha Gopal WarriarIndependent Director2025
Venkateswarlu JastiIndependent Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals Research & Developm₹0 Cr—
Segments — Geography
RegionRevenueShare
Within India₹70 Cr97.7%
Outside India₹2 Cr2.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1433232
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202552006213271
202551000121171
2025000000
Insider / Designated-Person Trades

10 recent disclosure(s)

SUDHIR VALIAPledge · 18,00,000
RAKSHA VALIAPledge · 22,00,000
Dilip S. ShanghviAcquisition · 2,52,80,899
RAKSHA VALIAPledge · 19,00,000
Raksha ValiaPledge · 30,80,000
Raksha ValiaPledge · 10,00,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Pref. Allotment19/05/2026 · 3,85,10,000
Company Information
Incorporated2006
ChairmanDilip S Shanghvi
AuditorS R B C & Co LLP
Investor Email[email protected]
🌐 www.sparc.life ↗

📍 Sun Pharma Advanced Res Centre, Akota Road Akota, Vadodara, Gujarat, 390020

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Sotac Pharmaceuticals Ltd.Savita Oil Technolo. Ltd.South Indian BankSouth West Pinnacle Ltd.SP Apparels LimitedSpandana Sphoorty Fin Ltd.Spacenet Enters Ind Ltd.Shivalic Power Control LimitedSrinibas Pradhan Const LimitedSpeb Adhesives LimitedSpeciality Rest Ltd.Spectrum Electric Ind Ltd.All “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search